359 results on '"Projectafdeling ALS"'
Search Results
152. Dutch population structure across space, time and GWAS design
153. Current trends in the clinical trial landscape for amyotrophic lateral sclerosis
154. Is it accurate to classify ALS as a neuromuscular disorder?
155. Nerve ultrasound for diagnosing chronic inflammatory neuropathy: a multicenter validation study
156. Clinical outcomes in multifocal motor neuropathy: A combined cross-sectional and follow-up study
157. A placebo-controlled trial to investigate the safety and efficacy of Penicillin G/Hydrocortisone in patients with ALS (PHALS trial)
158. TRICALS: creating a highway toward a cure
159. The Beginning of Genomic Therapies for ALS
160. Use of Multimodal Imaging and Clinical Biomarkers in Presymptomatic Carriers of C9orf72 Repeat Expansion
161. The distinct traits of the UNC13A polymorphism in amyotrophic lateral sclerosis
162. A proposal for new diagnostic criteria for ALS
163. Progression of cognitive and behavioural impairment in early amyotrophic lateral sclerosis
164. Neuro-imaging in amyotrophic lateral sclerosis: Should we shift towards the periphery?
165. Using patient-reported symptoms of dyspnea for screening reduced respiratory function in patients with motor neuron diseases
166. Effect of Fixed-Density Thresholding on Structural Brain Networks: A Demonstration in Cerebral Small Vessel Disease
167. Transethnic Genome-Wide Association Study Provides Insights in the Genetic Architecture and Heritability of Long QT Syndrome
168. Blended psychosocial support for partners of patients with ALS and PMA: results of a randomized controlled trial
169. Multimodal longitudinal study of structural brain involvement in amyotrophic lateral sclerosis
170. Relative hyperventilation in non-ventilated patients with spinal muscular atrophy
171. Prognostic value of weight loss in patients with amyotrophic lateral sclerosis: a population-based study
172. Connectome-based propagation model in amyotrophic lateral sclerosis
173. Analysis of FUS, PFN2, TDP-43, and PLS3 as potential disease severity modifiers in spinal muscular atrophy
174. Primary lateral sclerosis: consensus diagnostic criteria
175. In pursuit of the normal progressor: the holy grail for ALS clinical trial design?
176. T2 relaxation-time mapping in healthy and diseased skeletal muscle using extended phase graph algorithms
177. Natural history of lung function in spinal muscular atrophy
178. Psychological distress in partners of patients with amyotrophic lateral sclerosis and progressive muscular atrophy: what's the role of care demands and perceived control?
179. Assessment of motor unit loss in patients with spinal muscular atrophy
180. Associations between illness cognitions and health-related quality of life in the first year after diagnosis of amyotrophic lateral sclerosis
181. Telehealth as part of specialized ALS care: feasibility and user experiences with 'ALS home-monitoring and coaching'
182. The current use of telehealth in ALS care and the barriers to and facilitators of implementation: a systematic review
183. In training for a marathon: Runners and running-related injury prevention
184. Drug treatment for spinal muscular atrophy types II and III
185. Addressing heterogeneity in amyotrophic lateral sclerosis CLINICAL TRIALS
186. Development and assessment of the inter-rater and intra-rater reproducibility of a self-administration version of the ALSFRS-R
187. Nerve ultrasound improves detection of treatment-responsive chronic inflammatory neuropathies
188. Multifocal motor neuropathy: controversies and priorities
189. Effect modification of the association between total cigarette smoking and ALS risk by intensity, duration and time-since-quitting: Euro-MOTOR
190. KIF1A variants are a frequent cause of autosomal dominant hereditary spastic paraplegia
191. Pharmacogenetic interactions in amyotrophic lateral sclerosis: a step closer to a cure?
192. This title is unavailable for guests, please login to see more information.
193. Hartmann's procedure versus sigmoidectomy with primary anastomosis for perforated diverticulitis with purulent or faecal peritonitis (LADIES): a multicentre, parallel-group, randomised, open-label, superiority trial
194. Human immune globulin 10% with recombinant human hyaluronidase in multifocal motor neuropathy
195. Validated inference of smoking habits from blood with a finite DNA methylation marker set
196. Association between alcohol exposure and the risk of amyotrophic lateral sclerosis in the Euro-MOTOR study
197. Support needs of caregivers of patients with amyotrophic lateral sclerosis: A qualitative study
198. Loss of appetite is associated with a loss of weight and fat mass in patients with amyotrophic lateral sclerosis
199. Occupation and motor neuron disease: a New Zealand case-control study
200. Two heads are better than one: benefits of joint models for ALS trials
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.